High-level Expression and in Vitro Mutagenesis of a Fibrillogenic 109-amino-acid C-terminal Fragment of Alzheimer's-disease Amyloid Precursor Protein

Overview

Journal Biochem J

Specialty Biochemistry

Date 1993 Sep 15

PMID 8379923

Authors

J E Gardella

G A Gorgone

L Candela

J Ghiso

E M Castano

B Frangione

P D Gorevic

Affiliations

Soon will be listed here.

Abstract

We amplified DNA encoding the 3' 109 codons of Alzheimer's-disease amyloid precursor protein (APP) inclusive of the beta protein (A beta) and cytoplasmic domains from cDNA using oligonucleotide primers designed to facilitate cloning into the T7 expression vector pT7Ad23K13. We also modified this construct to generate recombinant molecules incorporating two recently described APP mutants by site-directed mutagenesis. Both native C109 (deletion construct inclusive of the C-terminal 109 residues of APP) and constructs with a single mutation at codon 642 (T-->G, resulting in a substitution of glycine for valine) or a double mutation at codons 595 (G-->T, substituting asparagine for lysine) and 596 (A-->C, substituting leucine for methionine) were expressed in Escherichia coli to levels of 5-20% of total bacterial protein after induction. The major constituent of expressed C109 protein had an apparent molecular mass of 16-18 kDa by SDS/PAGE and appeared to be the full-length construct by size and N-terminal microsequencing. Also present was a 4-5 kDa species that co-purified with C109, constituting only approximately 1% of expressed protein, which was revealed by Western-blot analysis with antibodies specific for A beta epitopes and after biotinylation of purified recombinant C109. This fragment shared N-terminal sequence with, and appeared to arise by proteolysis of, full-length C109 in biosynthetic labelling experiments. C109 spontaneously precipitated after dialysis against NaCl or water, and with prolonged (> 20 weeks) standing was found by electron microscopy to contain a minor (< 5%) fibrillar component that was reactive with antibodies to a C-terminal epitope of APP. Recombinant C109 appears to duplicate some of the biochemical and physicochemical properties of C-terminal A beta-inclusive fragments of APP that have been found in transfected cells, brain cortex and cerebral microvessels.

References

Tamaoka A, Kalaria R, Lieberburg I, Selkoe D . Identification of a stable fragment of the Alzheimer amyloid precursor containing the beta-protein in brain microvessels. Proc Natl Acad Sci U S A. 1992; 89(4):1345-9. PMC: 48446. DOI: 10.1073/pnas.89.4.1345. View

Maruyama K, Usami M, Tagawa K, Ishiura S . Mutation of Glu693 to Gln or Val717 to Ile has no effect on the processing of Alzheimer amyloid precursor protein expressed in COS-1 cells by cDNA transfection. Neurosci Lett. 1991; 132(1):97-100. DOI: 10.1016/0304-3940(91)90442-v. View

Caporaso G, Gandy S, Buxbaum J, Greengard P . Chloroquine inhibits intracellular degradation but not secretion of Alzheimer beta/A4 amyloid precursor protein. Proc Natl Acad Sci U S A. 1992; 89(6):2252-6. PMC: 48635. DOI: 10.1073/pnas.89.6.2252. View

Caporaso G, Gandy S, Buxbaum J, Ramabhadran T, Greengard P . Protein phosphorylation regulates secretion of Alzheimer beta/A4 amyloid precursor protein. Proc Natl Acad Sci U S A. 1992; 89(7):3055-9. PMC: 48802. DOI: 10.1073/pnas.89.7.3055. View

Colon W, Kelly J . Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry. 1992; 31(36):8654-60. DOI: 10.1021/bi00151a036. View

Gardella J, Gorgone G, Munoz P, Ghiso J, Frangione B, Gorevic P . Beta protein precursor expression in human platelets and a megakaryocyte cell line. Possible implications for the origin of cerebral amyloidosis in Alzheimer's disease. Lab Invest. 1992; 67(3):303-13. View

Seubert P, Esch F, Lee M, Dovey H, Davis D, Sinha S . Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature. 1992; 359(6393):325-7. DOI: 10.1038/359325a0. View

Fraser P, Nguyen J, Inouye H, Surewicz W, Selkoe D, Podlisny M . Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid beta-protein. Biochemistry. 1992; 31(44):10716-23. DOI: 10.1021/bi00159a011. View

Shoji M, Golde T, Ghiso J, Cheung T, Estus S, Shaffer L . Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science. 1992; 258(5079):126-9. DOI: 10.1126/science.1439760. View

10.

Adams K, Yeh M, Sapolsky R . Failure of beta-amyloid protein fragment 25-35 to cause hippocampal damage in the rat. Neurobiol Aging. 1992; 13(5):577-9. DOI: 10.1016/0197-4580(92)90058-6. View

11.

Citron M, Oltersdorf T, Haass C, McConlogue L, Hung A, Seubert P . Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature. 1992; 360(6405):672-4. DOI: 10.1038/360672a0. View

12.

Ghiso J, Rostagno A, Gardella J, Liem L, Gorevic P, Frangione B . A 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein contains a sequence, -RHDS-, that promotes cell adhesion. Biochem J. 1992; 288 ( Pt 3):1053-9. PMC: 1131993. DOI: 10.1042/bj2881053. View

13.

Cai X, Golde T, Younkin S . Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science. 1993; 259(5094):514-6. DOI: 10.1126/science.8424174. View

14.

Anderson C . Expression and purification of the adenovirus proteinase polypeptide and of a synthetic proteinase substrate. Protein Expr Purif. 1993; 4(1):8-15. DOI: 10.1006/prep.1993.1002. View

15.

Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B . A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet. 1992; 1(5):345-7. DOI: 10.1038/ng0892-345. View

16.

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

17.

Bayer E, Wilchek M . The use of the avidin-biotin complex as a tool in molecular biology. Methods Biochem Anal. 1980; 26:1-45. DOI: 10.1002/9780470110461.ch1. View

18.

Kirschner D, Abraham C, Selkoe D . X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation. Proc Natl Acad Sci U S A. 1986; 83(2):503-7. PMC: 322888. DOI: 10.1073/pnas.83.2.503. View

19.

Wada A, Sako T . Primary structures of and genes for new ribosomal proteins A and B in Escherichia coli. J Biochem. 1987; 101(3):817-20. DOI: 10.1093/jb/101.3.817. View

20.

Gorevic P, Castano E, Sarma R, Frangione B . Ten to fourteen residue peptides of Alzheimer's disease protein are sufficient for amyloid fibril formation and its characteristic x-ray diffraction pattern. Biochem Biophys Res Commun. 1987; 147(2):854-62. DOI: 10.1016/0006-291x(87)91008-4. View